These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4408226)

  • 21. [Therapy of bacterial infections in infants and children. Report of 171 cases treated with trimethoprim-sulfamethoxazol].
    Keuth U; Sabbagh M; Thesen E
    Munch Med Wochenschr; 1970 Apr; 112(17):802-6. PubMed ID: 5467989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytostatic side effects of thiamphenicol: alopecia, reversible cytopenia].
    Moeschlin S; Novotný Z; Koller F; Rüefli P
    Schweiz Med Wochenschr; 1974 Mar; 104(11):384-7. PubMed ID: 4815311
    [No Abstract]   [Full Text] [Related]  

  • 23. [Initial experience with cefotiam in respiratory and urinary tract infections].
    Havlík J
    Cesk Pediatr; 1990 Apr; 45(4):240-1. PubMed ID: 2249284
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary tract infections in the 1980s.
    Neu HC
    Semin Urol; 1983 May; 1(2):130-7. PubMed ID: 6332360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the hematoxicity of thiamphenicol. 1. Clinical-hematological results].
    Kaltwasser JP; Simon B; Werner E; Stille W; Becker H
    Arzneimittelforschung; 1974 Feb; 24(2):190-95. PubMed ID: 4406369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ampicillin potassium in the treatment of bacterial infections].
    Fry W
    Hospital (Rio J); 1970 Apr; 77(4):1291-301. PubMed ID: 4939511
    [No Abstract]   [Full Text] [Related]  

  • 28. Ampicillin in acute infections of general practice. A controlled trial.
    Lake B
    Med J Aust; 1971 Mar; 1(12):636-40. PubMed ID: 4928755
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with cephalexin monohydrate of urinary tract infections in children. Preliminary report].
    De La Torre JA; Filloy L; Mendez Tena E; Olarte J; Torregrosa L
    Prensa Med Mex; 1970; ():87-91. PubMed ID: 4931124
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with sulphormethoxine: a new long-acting sulphonamide.
    McGuinness BW
    Br J Clin Pract; 1969 Aug; 23(8):331-4. PubMed ID: 5801679
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of the posology of 2-sulfanylamido-3-methoxy-pyrazine (sulfamethopyrazine)].
    Di Nola F; Rapellini M; Pasquale A; Guasco C
    Minerva Med; 1966 Jun; 57(45):2059-67. PubMed ID: 5939218
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cephalexin monohydrate in pediatrics. Clinical, bacteriological experiences and the hematic, hepatic and renal tolerance in 120 children with respiratory infections].
    Albores JM; Martinez Meyer CA; Ots TP; Guilhem A; Bures OM; Mendez J; Lopez Scala Z
    Prensa Med Mex; 1970; ():100-7. PubMed ID: 4931110
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remarks on the in vitro hydrolysis and on the adsorption in the animals and man of a new synthetic ester: thiamphenicol palmitate.
    Della Bella D; Veronese M; Marca G; Franceschinis R
    Arzneimittelforschung; 1974 May; 24(5):836-9. PubMed ID: 4408346
    [No Abstract]   [Full Text] [Related]  

  • 35. [Details on the behavior of leukocytosis and of the leukocyte formula after corticoid therapy in childhood].
    Varese LA
    Minerva Pediatr; 1968 Mar; 20(11):642-5. PubMed ID: 5739035
    [No Abstract]   [Full Text] [Related]  

  • 36. Netilmicin in urinary tract infections.
    Svare J; Johnsen NJ; Vesterhauge S; Lund F; Thomsen J; Vejlsgaard R
    Scand J Infect Dis Suppl; 1980; Suppl 23():132-4. PubMed ID: 6937957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicolaboratory experience with cephalexin.
    Stratford BC
    Postgrad Med J; 1970 Oct; ():Suppl:138-41. PubMed ID: 5488195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amoxicillin in severe infections: preliminary results.
    Corrêa Lima MB
    J Infect Dis; 1974 Jun; 129(0):suppl:S207-8. PubMed ID: 4600881
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics].
    Biscatti G; Bruschelli M; Damonte G; Capozzi F
    Minerva Pediatr; 1972 Jul; 24(26):1075-84. PubMed ID: 5069821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.